Most Cited 2009 Paper from Cancer Research

Andrea Sartore-Bianchi, Miriam Martini, Francesca Molinari, Silvio Veronese, Michele Nichelatti, Salvatore Artale, Federica Di Nicolantonio, Piercarlo Saletti, Sara De Dosso, Luca Mazzucchelli, Milo Frattini, Salvatore Siena, Alberto Bardelli
(Drs. Frattini, Siena, and Bardelli pictured to the right)

PIK3CA Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies

Cancer Research, March 1, 2009, 69(5):1851–1857

---

Most Cited 2009 Paper from Clinical Cancer Research

Min H. Kang and C. Patrick Reynolds

Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy

Clinical Cancer Research, February 15, 2009, 15(4):1126–1132

---

Most Cited 2009 Paper from Cancer Prevention Research

Anupam Bishayee

Cancer Prevention and Treatment with Resveratrol: From Rodent Studies to Clinical Trials

Cancer Prevention Research, May 2009, 2(5):409–418 

---

Most Cited 2009 Paper from Cancer Epidemiology, Biomarkers, & Prevention

Lindsey Enewold, Kangmin Zhu, Elaine Ron, Aizen J. Marrogi, Alexander Stojadinovic, George E. Peoples, Susan S. Devesa
(Dr. Enewold pictured to the right)

Rising Thyroid Cancer Incidence in the United States by Demographic and Tumor Characteristics, 1980–2005

Cancer Epidemiology, Biomarkers & Prevention, March 2009, 18(3):784–791

---

Most Cited 2009 Paper from Molecular Cancer Research

Geoffrey M. Wahl and Mark Wade

Targeting Mdm2 and Mdmx in Cancer Therapy: Better Living through Medicinal Chemistry?

Molecular Cancer Research, January 2009, 7(1):1–11

---

Most Cited 2009 Paper from Molecular Cancer Therapeutics

Nathan T. Ihle and Garth Powis

Take your PIK: phosphatidylinositol 3-kinase inhibitors race through the clinic and toward cancer therapy

Molecular Cancer Therapeutics, January 2009, 8(1): 1–9